Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer
One year of treatment with trastuzumab after adjuvant chemotherapy significantly improves disease-free survival among women with HER2-positive breast cancer. (ClinicalTrials.gov...